Neurocrine Biosciences | NBIX - Saham





Saham Perubahan Tanggal
AbbVie USD 5.31B 178M 2026-09
Acadia Pharmaceuticals USD 40.36M 68.31M 2026-09
Agios Pharmaceuticals USD 37.84M 2.09M 2026-09
ALKERMES USD 261.1M 37.86M 2026-09
Alnylam Pharmaceuticals USD 105.91M 8.8M 2026-09
Amgen USD 6.39B 169M 2026-09
Biogen USD 2.22B 159.9M 2026-09
BioMarin Pharmaceutical USD 1.8B 13.54M 2026-09
Cytokinetics USD 807K 427K 2026-09
Exelixis USD 29.87M 1.14M 2026-09
Gilead Sciences USD 1.9B 57M 2026-09
Halozyme Therapeutics USD 132.61M 4.52M 2026-09
Incyte USD 134.25M 21.71M 2026-09
Ionis Pharmaceuticals USD 50.83M 45.28M 2026-06
Nektar Therapeutics USD 14.46M 1.78M 2024-06
Neurocrine Biosciences USD 66.1M 38.1M 2026-09
Pfizer USD 10.02B 77M 2026-09
Regeneron Pharmaceuticals USD 2.89B 189.7M 2026-09
Repligen USD 182.2M 4.4M 2026-09
Rigel Pharmaceuticals USD 13.3M 2.88M 2025-09
Sarepta Therapeutics USD 876.12M 28.15M 2026-09
Teva Pharmaceutical Industries USD 3.17B 48M 2026-09
Ultragenyx Pharmaceutical USD 59M 0 2026-09
Vertex Pharmaceuticals USD 2.25B 480.2M 2026-09